Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
Clinical trial NCT01136161 · COMPLETED
Trial details
- NCT number
- NCT01136161
- Sponsor
- Archivel Farma S.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-05-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.